Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu List Pharmaceutical is a Chinese pharmaceutical company headquartered in Chengdu, Sichuan, specializing in the development and manufacture of chemical generic drugs. Founded in 2001, the company has established a robust portfolio focusing on therapeutic areas such as cardiovascular health, gastroenterology, and infectious diseases. It operates state-of-the-art, GMP-certified manufacturing facilities that produce a variety of oral solid dosage forms and active pharmaceutical ingredients. The company is recognized for its commitment to quality and its role in providing affordable medication within the Chinese healthcare system. Its key products include widely prescribed treatments for hypertension and gastric disorders, such as amlodipine and rabeprazole.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu List Pharmaceutical.